Manufacturers
Drugs by Boehringer Ingelheim International GmbH
44 drugs for which Boehringer Ingelheim International GmbH holds the marketing authorisation in UK.
APTIVUS 100 mg/ml oral solutionTipranavir · Boehringer Ingelheim International GmbH- APTIVUS 250 mg soft capsulesTipranavir · Boehringer Ingelheim International GmbH
- BEROMUN 1 mg/5 ml powder and solvent for solution forinfusionTasonermin · Boehringer Ingelheim International GmbH
- Metalyse 10,000 units. Powder and solvent for solution forinjectionTenecteplase · Boehringer Ingelheim International GmbH
- Metalyse 6,000 units. Powder and solvent for solution forinjectionTenecteplase · Boehringer Ingelheim International GmbH
- Metalyse 8,000 units. Powder and solvent for solution forinjectionTenecteplase · Boehringer Ingelheim International GmbH
- Micardis 20 mg tabletsTelmisartan · Boehringer Ingelheim International GmbH
- Micardis 40 mg tabletsTelmisartan · Boehringer Ingelheim International GmbH
- Micardis 80 mg tabletsTelmisartan · Boehringer Ingelheim International GmbH
- MicardisPlus 40 mg/12.5 mg tabletsBoehringer Ingelheim International GmbH
- MicardisPlus 80 mg/12.5 mg tabletsBoehringer Ingelheim International GmbH
- MicardisPlus 80 mg/25 mg tabletsBoehringer Ingelheim International GmbH
- MIRAPEXIN 0.088 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 0.18 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 0.26 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 0.35 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 0.52 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 0.7 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 1.05 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 1.1 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 1.57 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 2.1 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 2.62 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- MIRAPEXIN 3.15 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- Pradaxa 110 mg hard capsulesDabigatran etexilate · Boehringer Ingelheim International GmbH
- Pradaxa 75 mg hard capsulesDabigatran etexilate · Boehringer Ingelheim International GmbH
- SIFROL 0.088 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 0.18 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 0.26 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 0.35 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 0.52 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 0.7 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 1.05 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 1.1 mg tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 1.57 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 2.1 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 2.62 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- SIFROL 3.15 mg prolonged-release tabletsPramipexole · Boehringer Ingelheim International GmbH
- TWYNSTA 40 mg/10 mg tabletsBoehringer Ingelheim International GmbH
- TWYNSTA 40 mg/5 mg tabletsBoehringer Ingelheim International GmbH
- TWYNSTA 80 mg/10 mg tabletsBoehringer Ingelheim International GmbH
- TWYNSTA 80 mg/5 mg tabletsBoehringer Ingelheim International GmbH
- VIRAMUNE 200 mg tabletsNevirapine · Boehringer Ingelheim International GmbH
- VIRAMUNE 50 mg/5 ml oral suspensionNevirapine · Boehringer Ingelheim International GmbH
Advertisement